. . . . . . . . . . . . . . "m(HGNC:MIR106B) -| p(HGNC:CDKN1A)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "As shown in Fig. 2B, transfected precursor miR-106b decreased p21/ WAF1 protein levels and antisense miR-106b increased p21/WAF1 protein levels in the two cell lines. We obtained the same results for E2F1 after transfection of the prostate cancer cells with precursor and antisense miR-106b (Fig. 3A)...........E2F1and Bim are direct targets of miR-32 and miR-106b." . . "Selventa" . . . . "2014-07-03T14:33:23.781+02:00"^^ . . .